跳至主要内容
临床试验/NCT02757235
NCT02757235已完成不适用

The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma - A Multicenter Randomised Controlled Trial

Sahlgrenska University Hospital, Sweden3 个研究点 分布在 1 个国家目标入组 588 人开始时间: 2016年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
588
试验地点
3
主要终点
Recurrence rate

研究概览

简要总结

The study will be a multicenter randomised controlled trial of the use of irrigation fluid of body temperature versus irrigation fluid of room temperature during burr hole evacuation of chronic subdural hematoma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with chronic subdural hematoma requiring burr hole evacuation.
  • •Patients older than 18 years of age.

排除标准

  • •Chronic subdural hematoma requiring surgical treatment other than burr hole evacuation.
  • •Chronic subdural hematoma in a patient with an intracranial arachnoidal cyst.
  • •Chronic subdural hematoma in a patient with a Cerebro Spinal Fluid-shunt.
  • •Patients who have undergone intracranial surgery before.

研究组 & 干预措施

Irrigation fluid of body temperature

Active Comparator

During burr hole evacuation of the chronic subdural hematoma the irrigation fluid used will be of body temperature (approximately 37 degrees Celsius)

干预措施: Irrigation fluid of body temperature (Procedure)

Irrigation fluid of room temperature

Active Comparator

During burr hole evacuation of the chronic subdural hematoma the irrigation fluid used will be of room temperature (approximately 22 degrees Celsius)

干预措施: Irrigation fluid of room temperature (Procedure)

结局指标

主要结局

Recurrence rate

时间窗: 6 months

Recurrences requiring repeat surgery during a 6-month follow up period

次要结局

  • Mortality(6 months)
  • Complications related to the surgery(6 months)
  • Health related quality of life(6 months)

研究者

发起方
Sahlgrenska University Hospital, Sweden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Bartley

MD, neurosurgical resident

Sahlgrenska University Hospital, Sweden

研究点 (3)

Loading locations...

相似试验